Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E. Yohe, David M. Langenau, Douglas S. Hawkins et al.|Pediatric Blood & Cancer|2019Cited by 79
Myogenic regulatory transcription factors regulate growth in rhabdomyosarcomaInês M. Tenente, David M. Langenau, Madeline N. Hayes et al.|eLife|2017Cited by 74
The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal RhabdomyosarcomaMyron S. Ignatius, David M. Langenau, Madeline N. Hayes et al.|Cell Reports|2017Cited by 68
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative RhabdomyosarcomaSilvia Pomella, Myron S. Ignatius, Prethish Sreenivas et al.|Nature Communications|2021Cited by 47
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task ForceHolly Pacenta, Theodore W. Laetsch, Wendy Allen‐Rhoades et al.|Journal of Clinical Medicine|2021Cited by 28